Rice Hall James & Associates’s Cardiovascular Systems, Inc. CSII Stock Holding History

Rice Hall James & Associates’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-90,832	Closed	-$3.87M	–	329
2021 Q2	$3.87M	Sell	90,832 -55,234	-38%	-$2.16M	0.14%	113
2021 Q1	$5.6M	Sell	146,066 -2,315	-2%	-$98.5K	0.18%	100
2020 Q4	$6.49M	Sell	148,381 -25,129	-14%	-$946K	0.23%	84
2020 Q3	$6.83M	Sell	173,510 -24,416	-12%	-$789K	0.28%	78
2020 Q2	$6.25M	Buy	197,926 +173,996	+727%	+$6.5M	0.27%	103
2020 Q1	$843K	Sell	23,930 -786	-3%	-$33.1K	0.05%	214
2019 Q4	$1.2M	Sell	24,716 -9,261	-27%	-$422K	0.04%	223
2019 Q3	$1.61M	Sell	33,977 -9,575	-22%	-$450K	0.06%	196
2019 Q2	$1.87M	Sell	43,552 -13,720	-24%	-$533K	0.06%	191
2019 Q1	$2.21M	Sell	57,272 -1,626	-3%	-$55.1K	0.07%	173
2018 Q4	$1.68M	Buy	+58,898	New	+$1.87M	0.06%	199

Other funds holding CSII

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rice Hall James & Associates's CSII Position: Q3 2021 in Review

Rice Hall James & Associates sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2021, closing a stake of 90,832 shares — an estimated $3.87M sold.

Rice Hall James & Associates first reported a position in CSII in Q4 2018 and held it in 11 quarters. The position peaked at $6.83M in Q3 2020. 171 funds tracked by Wall St. Rank hold CSII as of Q3 2021.

Rice Hall James & Associates reported no remaining Cardiovascular Systems, Inc. position as of Q3 2021 after selling out during the quarter.
Rice Hall James & Associates sold 90,832 Cardiovascular Systems, Inc. shares in Q3 2021, an estimated $3.87M.
Rice Hall James & Associates first reported a position in Cardiovascular Systems, Inc. in Q4 2018 and held it in 11 quarters.
Rice Hall James & Associates's Cardiovascular Systems, Inc. position peaked at $6.83M in Q3 2020.
171 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2021.

Based on Rice Hall James & Associates's 13F filing for Q3 2021, filed 9 Nov 2021.